BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1148061)

  • 1. Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure.
    Beregovich J; Bianchi C; D'Angelo R; Diaz R; Rubler S
    Br Heart J; 1975 Jun; 37(6):629-34. PubMed ID: 1148061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative haemodynamic effects of dobutamine and isoproterenol in man.
    Rigaud M; Boschat J; Rocha P; Ferreira A; Bardet J; Bourdarias JP
    Intensive Care Med; 1977 Aug; 3(2):57-62. PubMed ID: 893774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dobutamine, a new beta agonist.
    Holloway GA; Frederickson EL
    Anesth Analg; 1974; 53(4):616-23. PubMed ID: 4152188
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemodynamic effects of dobutamine in patients with coronary artery disease.
    Magnani B; Ambrosioni E; Branzi A; Picchio F; Capitanucci P
    J Int Med Res; 1977; 5(1):10-7. PubMed ID: 838109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of intravenous butopamine in congestive heart failure.
    Thompson MJ; Huss P; Unverferth DV; Fasola A; Leier CV
    Clin Pharmacol Ther; 1980 Sep; 28(3):324-34. PubMed ID: 7408391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
    Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of dobutamine in patients following open heart surgery.
    Sakamoto T; Yamada T
    Circulation; 1977 Mar; 55(3):525-33. PubMed ID: 837487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
    Jewitt D; Birkhead J; Mitchell A; Dollery C
    Lancet; 1974 Aug; 2(7877):363-7. PubMed ID: 4136593
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure.
    Leier CV; Unverferth DV; Kates RE
    Am J Med; 1979 Feb; 66(2):238-42. PubMed ID: 425967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haemodynamic and vascular effects of dobutamine during and after open heart operations (author's transl)].
    Piepenbrock S; Hempelmann G; Reichelt W; Stegmann T
    Anaesthesist; 1979 Jul; 28(7):307-15. PubMed ID: 314759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
    Leier CV; Webel J; Bush CA
    Circulation; 1977 Sep; 56(3):468-72. PubMed ID: 884803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effect of isoprenaline and dobutamine immediately after correction of tetralogy of Fallot. Relative importance of inotropic and chronotropic action in supporting cardiac output.
    Jaccard C; Berner M; Rouge JC; Oberhänsli I; Friedli B
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):862-9. PubMed ID: 6727409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of cardiovascular effects of dobutamine and dopamine (author's transl)].
    Hess W; Brückner JB; Schmidt D; Schweichel E; Tarnow J
    Z Kardiol; 1977 Oct; 66(10):537-44. PubMed ID: 919662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure.
    Takatsu Y; Yui Y; Hattori R; Sakaguchi K; Susawa T; Yui N; Kawai C
    Jpn Circ J; 1987 Jun; 51(6):611-6. PubMed ID: 3312701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
    Parodi O; Crea F; Pesola A; Distante A; Chierchia S; Moscarelli E; L'Abbate A; Maseri A
    G Ital Cardiol; 1980; 10(9):1141-7. PubMed ID: 7193152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dobutamine and dopamine in treatment of severe heart failure.
    Stoner JD; Bolen JL; Harrison DC
    Br Heart J; 1977 May; 39(5):536-9. PubMed ID: 324501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.